MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
Kwok, Brian, Hall, Jeff M., Witte, John S., Xu, Yin, Reddy, Prashanti, Lin, Keming, Flamholz, Rachel, Dabbas, Bashar, Yung, Aine, Al-Hafidh, Jenan, Balmert, Emily, Vaupel, Christine, El Hader, Carlos, McGinniss, Matthew J., Nahas, Shareef A., Kines, Julie, Bejar, Rafael
Published in Blood (19.11.2015)
Published in Blood (19.11.2015)
Get full text
Journal Article
Targeted Next-Generation Sequencing of TP53, BIRC3, NOTCH1, SF3B1, and ATM Identifies a Significant Proportion of Lower-Risk Chronic Lymphocytic Leukemia with Unfavorable Prognostic Indicators
Kwok, Brian, Yung, Aine, Reddy, Prashanti, Xu, Yin, Chan, Alex, Lyle, Derek
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Clinicopathologic Analysis of Calr Mutation Subtypes in Myeloproliferative Neoplasms
Xu, Yin, Kwok, Brian, Yung, Aine, Flamholz, Rachel, Wu, Zhao, Dabbas, Bashar, Reddy, Prashanti
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Next-Generation Sequencing (NGS)-Based Profiling of Idiopathic Cytopenia of Undetermined Significance (ICUS) Identifies a Subset of Patients with Genomic Similarities to Lower-Risk Myelodysplastic Syndrome (MDS)
Kwok, Brian, Reddy, Prashanti, Lin, Keming, Flamholz, Rachel, Yung, Aine, Dabbas, Bashar, McGinniss, Matthew, Nahas, Shareef, Kines, Julie, Xu, Yin
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Next-Generation Sequencing Of ASXL1, TP53, RUNX1, EZH2, and ETV6 Identifies a Significant Proportion Of Lower-Risk Myelodysplastic Syndromes With Poor Prognostic Indicators
Kwok, Brian, Mohrmann, Renee, Janatpour, Kim, Xu, Yin, McGinniss, Matthew, Yung, Aine, Drum, Hong, Lin, Keming, Kines, Julie, Tasmin, Jeffrey, Dabbas, Bashar
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article